These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 29525356)

  • 1. Looking back on the alternative complement pathway.
    Lachmann PJ
    Immunobiology; 2018; 223(8-9):519-523. PubMed ID: 29525356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A war with the molecules: Louis Pillemer and the history of properdin.
    Ratnoff WD
    Perspect Biol Med; 1980; 23(4):638-57. PubMed ID: 7010302
    [No Abstract]   [Full Text] [Related]  

  • 3. Presidential address to American Association of Immunologists in Anaheim, California, April 16, 1980. Louis Pillemer, Properdin, and scientific controversy.
    Lepow IH
    J Immunol; 1980 Aug; 125(2):471-5. PubMed ID: 6993558
    [No Abstract]   [Full Text] [Related]  

  • 4. Properdin: New roles in pattern recognition and target clearance.
    Kemper C; Hourcade DE
    Mol Immunol; 2008 Oct; 45(16):4048-56. PubMed ID: 18692243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification and functional analysis of human properdin.
    O'Flynn J; Krol MC; Daha MR; van Kooten C
    Methods Mol Biol; 2014; 1100():161-7. PubMed ID: 24218258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Properdin: a tightly regulated critical inflammatory modulator.
    Blatt AZ; Pathan S; Ferreira VP
    Immunol Rev; 2016 Nov; 274(1):172-190. PubMed ID: 27782331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation?
    Harrison RA
    Semin Immunopathol; 2018 Jan; 40(1):15-35. PubMed ID: 29167939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway.
    Shahraz A; Lin Y; Mbroh J; Winkler J; Liao H; Lackmann M; Bungartz A; Zipfel PF; Skerka C; Neumann H
    Sci Rep; 2022 Apr; 12(1):5818. PubMed ID: 35388026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation by tubular cells is mediated by properdin binding.
    Gaarkeuken H; Siezenga MA; Zuidwijk K; van Kooten C; Rabelink TJ; Daha MR; Berger SP
    Am J Physiol Renal Physiol; 2008 Nov; 295(5):F1397-403. PubMed ID: 18753294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The alternative complement pathway is dysregulated in patients with chronic heart failure.
    Shahini N; Michelsen AE; Nilsson PH; Ekholt K; Gullestad L; Broch K; Dahl CP; Aukrust P; Ueland T; Mollnes TE; Yndestad A; Louwe MC
    Sci Rep; 2017 Feb; 7():42532. PubMed ID: 28195242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway.
    Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH
    Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recombinant two-module form of human properdin is an inhibitor of the complement alternative pathway.
    Kouser L; Abdul-Aziz M; Tsolaki AG; Singhal D; Schwaeble WJ; Urban BC; Khan HA; Sim RB; Kishore U
    Mol Immunol; 2016 May; 73():76-87. PubMed ID: 27060503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fractionation of human plasma proteins. I. Affinity purification of human complement properdin.
    DiScipio RG
    Protein Expr Purif; 1994 Apr; 5(2):164-9. PubMed ID: 8054850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of properdin in amphioxus: Implications for a functional alternative complement pathway in the basal chordate.
    Gao Z; Ma Z; Qu B; Jiao D; Zhang S
    Fish Shellfish Immunol; 2017 Jun; 65():1-8. PubMed ID: 28366782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 34-amino acid peptide of the third component of complement mediates properdin binding.
    Daoudaki ME; Becherer JD; Lambris JD
    J Immunol; 1988 Mar; 140(5):1577-80. PubMed ID: 3279119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative Modeling of the Alternative Pathway of the Complement System.
    Zewde N; Gorham RD; Dorado A; Morikis D
    PLoS One; 2016; 11(3):e0152337. PubMed ID: 27031863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition by cinnarizine of the properdin-dependent activation of complement.
    Di Perri T; Auteri A; Pasini FL; Mattioli F
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):281-5. PubMed ID: 879911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properdin, a positive regulator of complement activation, is released from secondary granules of stimulated peripheral blood neutrophils.
    Wirthmueller U; Dewald B; Thelen M; Schäfer MK; Stover C; Whaley K; North J; Eggleton P; Reid KB; Schwaeble WJ
    J Immunol; 1997 May; 158(9):4444-51. PubMed ID: 9127010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.
    Goundis D; Reid KB
    Nature; 1988 Sep; 335(6185):82-5. PubMed ID: 3045564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of complement inactivation by glycoprotein C of herpes simplex virus.
    Kostavasili I; Sahu A; Friedman HM; Eisenberg RJ; Cohen GH; Lambris JD
    J Immunol; 1997 Feb; 158(4):1763-71. PubMed ID: 9029114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.